INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCHERS
ISSN: 3030-332X Impact factor: 8,293
Volume 10, issue 1, February 2025
https://wordlyknowledge.uz/index.php/IJSR
worldly knowledge
Index:
google scholar, research gate, research bib, zenodo, open aire.
https://scholar.google.com/scholar?hl=ru&as_sdt=0%2C5&q=wosjournals.com&btnG
https://www.researchgate.net/profile/Worldly-Knowledge
https://journalseeker.researchbib.com/view/issn/3030-332X
65
Khamdamov Botirjon Nusratullo ugli,Eshmamatova Fayyoza Boymamatovna,
Haydarov Og'abek Ulugbek ugli ,Tulayev Bobur Zoyir ugli
5th year students of the Faculty of Pediatrics of Samarkand State Medical University
Toshniyazova Gulrukhsor Sherzod qizi
4th year student of the Faculty of Treatment No.2
JOINT SYNDROME AND RHEUMATIC FEVER: CHARACTERISTICS OF THE
COURSE, PRIMARY AND SECONDARY PREVENTION, AND DISPENSARY
OBSERVATION
Abstract:
Joint syndrome is a common manifestation of various systemic diseases, particularly
rheumatic fever (RF), an inflammatory disease affecting connective tissues, predominantly in the
cardiovascular and musculoskeletal systems. The disease primarily develops as a post-
streptococcal complication and manifests through arthritis, carditis, and other systemic
symptoms. The course of rheumatic fever has distinct characteristics, including migratory
polyarthritis, recurrence patterns, and potential complications affecting the heart. Primary
prevention involves the early detection and treatment of streptococcal infections, while
secondary prevention focuses on long-term antibiotic prophylaxis to prevent recurrences.
Dispensary observation plays a crucial role in monitoring patients, ensuring timely intervention,
and reducing long-term complications. This article discusses the peculiarities of rheumatic fever,
its clinical progression, and the importance of prevention and long-term monitoring in affected
patients.
Keywords:
joint syndrome, rheumatic fever, arthritis, prevention, dispensary observation, post-
streptococcal infection.
Introduction
Joint syndrome is a broad term encompassing various pathological conditions affecting the joints,
often associated with systemic inflammatory diseases. One of the most significant causes of joint
syndrome in pediatric and young adult populations is rheumatic fever (RF), an autoimmune
response triggered by a previous Group A β-hemolytic streptococcal (GABHS) infection. RF
primarily affects the joints, heart, skin, and central nervous system, with long-term consequences
such as rheumatic heart disease (RHD), leading to chronic valvular damage.
The global burden of RF remains significant, particularly in developing countries, where
inadequate treatment of streptococcal pharyngitis contributes to its prevalence. Early diagnosis
and appropriate management are essential to prevent severe complications, particularly in the
cardiovascular system. Understanding the clinical course, primary and secondary prevention
strategies, and the role of dispensary observation is crucial for effective management and long-
term outcomes.
Relevance of the Topic
Rheumatic fever remains a major public health concern, especially in low-income regions with
limited access to healthcare. The World Health Organization (WHO) estimates that more than 33
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCHERS
ISSN: 3030-332X Impact factor: 8,293
Volume 10, issue 1, February 2025
https://wordlyknowledge.uz/index.php/IJSR
worldly knowledge
Index:
google scholar, research gate, research bib, zenodo, open aire.
https://scholar.google.com/scholar?hl=ru&as_sdt=0%2C5&q=wosjournals.com&btnG
https://www.researchgate.net/profile/Worldly-Knowledge
https://journalseeker.researchbib.com/view/issn/3030-332X
66
million people worldwide suffer from rheumatic heart disease, with over 300,000 deaths
annually. The lack of early diagnosis and prophylactic treatment increases the risk of recurrent
episodes, leading to severe cardiac damage.
The importance of primary and secondary prevention cannot be overstated, as timely
intervention can significantly reduce the incidence and severity of RF and RHD. Moreover,
dispensary observation plays a crucial role in preventing recurrences, ensuring compliance with
long-term antibiotic prophylaxis, and monitoring for potential complications. This article
highlights the distinctive features of RF, its clinical course, and the importance of structured
preventive measures in reducing its impact on affected populations.
Analysis and Discussion
1. Characteristics of Rheumatic Fever and Joint Syndrome
Rheumatic fever typically manifests 2-4 weeks after an untreated or inadequately treated
streptococcal throat infection. The disease follows an autoimmune mechanism, where cross-
reactivity between streptococcal antigens and host tissues leads to inflammation in the joints,
heart, skin, and nervous system.
Key Clinical Features of RF
Migratory Polyarthritis – the most common symptom, affecting large joints (knees, ankles,
elbows, and wrists). The inflammation is temporary, with each joint typically affected for 1–2
weeks.
Carditis – inflammation of the heart structures, leading to valvular damage (often affecting the
mitral and aortic valves). It is the most severe manifestation, with long-term implications.
Chorea (Sydenham’s Chorea) – involuntary, purposeless movements due to autoimmune
involvement of the basal ganglia.
Erythema Marginatum – a characteristic pink, non-itchy rash seen in some cases.
Subcutaneous Nodules – firm, painless nodules appearing over bony prominences in chronic
cases.
2. Distinctive Features of the Disease Course
The progression of RF varies among patients, but it often follows a recurring pattern, especially
without proper prophylaxis.
Acute Phase – inflammation predominates, with symptoms resolving within 6-12 weeks in most
cases.Recurrent Episodes – typically more severe than the initial episode, with an increased risk
of cardiac complications.
Chronic Rheumatic Heart Disease (RHD) – develops in 30-50% of patients with recurrent RF,
leading to heart valve damage and heart failure.
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCHERS
ISSN: 3030-332X Impact factor: 8,293
Volume 10, issue 1, February 2025
https://wordlyknowledge.uz/index.php/IJSR
worldly knowledge
Index:
google scholar, research gate, research bib, zenodo, open aire.
https://scholar.google.com/scholar?hl=ru&as_sdt=0%2C5&q=wosjournals.com&btnG
https://www.researchgate.net/profile/Worldly-Knowledge
https://journalseeker.researchbib.com/view/issn/3030-332X
67
Factors influencing the severity of RF include:Age – Children aged 5-15 years are at the highest
risk.Genetic Predisposition – Certain HLA types increase susceptibility.Socioeconomic Status –
Overcrowded living conditions facilitate streptococcal transmission.
Primary and Secondary Preventio
n
1. Primary Prevention
The goal of primary prevention is to prevent the first episode of RF by promptly diagnosing and
treating GABHS pharyngitis.
Early Identification of Streptococcal Infections – Rapid antigen detection tests (RADTs) and
throat cultures are essential for accurate diagnosis.
Antibiotic Therapy –Penicillin V (oral) for 10 days or Benzathine Penicillin G (intramuscular,
single dose) is the standard treatment.Erythromycin or azithromycin is used for penicillin-
allergic patients.Public Health Measures – Improving hygiene and access to healthcare reduces
streptococcal transmission.
2. Secondary Prevention
Secondary prevention aims to prevent recurrent episodes in individuals with a history of RF.
Long-term Antibiotic Prophylaxis –
Benzathine Penicillin G (IM every 3-4 weeks) is the preferred regimen.Oral Penicillin or
Erythromycin is an alternative for compliant patients.
Duration of Prophylaxis
Without carditis: at least 5 years or until age 21.
With carditis but no valve damage: 10 years or until age 25.
With RHD: lifelong prophylaxis.
Dispensary Observation
Dispensary observation plays a vital role in managing RF patients by:
1. Regular Clinical Evaluation – Assessing joint and cardiac status every 3-6 months.
2. Echocardiography Monitoring – Detecting early signs of valvular damage.
3. Compliance with Prophylaxis – Ensuring adherence to long-term antibiotic therapy.
4. Patient and Family Education – Informing about the importance of prevention and early signs
of recurrence.
Multidisciplinary care involving pediatricians, cardiologists, and rheumatologists improves
outcomes and reduces complications.
Conclusion
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCHERS
ISSN: 3030-332X Impact factor: 8,293
Volume 10, issue 1, February 2025
https://wordlyknowledge.uz/index.php/IJSR
worldly knowledge
Index:
google scholar, research gate, research bib, zenodo, open aire.
https://scholar.google.com/scholar?hl=ru&as_sdt=0%2C5&q=wosjournals.com&btnG
https://www.researchgate.net/profile/Worldly-Knowledge
https://journalseeker.researchbib.com/view/issn/3030-332X
68
Rheumatic fever remains a significant cause of joint syndrome and cardiovascular complications
worldwide. Early recognition, prompt antibiotic treatment, and long-term prophylaxis are crucial
in preventing severe outcomes, particularly rheumatic heart disease. Primary prevention targets
streptococcal infections, while secondary prevention focuses on suppressing recurrent RF
episodes. Dispensary observation ensures continuous monitoring, improving patient compliance
and prognosis. Strengthening public health interventions and increasing awareness among
healthcare providers are essential steps in reducing the burden of RF globally.
References:
1. Behar, J., & Fried, G. M. (2019). Disorders of the Biliary Tract: Diagnosis and Treatment.
Gastroenterology Clinics of North America, 48(4), 601–619.
2. Acalovschi, M. (2001). Biliary Dyskinesia: Clinical Features and Current Therapeutic
Options. World Journal of Gastroenterology, 7(3), 313–317.
3. Portincasa, P., Moschetta, A., & Palasciano, G. (2006). Dysmotility Disorders of the Biliary
Tract: From Pathophysiology to Therapy. Current Gastroenterology Reports, 8(2), 151–158.
4. Mottin, C. C., Lehmann, M., & Ramos, R. J. (2002). Biliary Dyskinesia: Diagnostic and
Therapeutic Aspects. International Journal of Digestive Diseases, 3(1), 45–50.
5. Sáinz, S., de la Ossa, J. C., & Bermejo, F. (2003). Gallbladder Dysmotility Disorders:
Pathogenesis, Diagnosis, and Management. Journal of Hepato-Biliary-Pancreatic Surgery,
10(5), 436–442
